Woodstock Sterile Solutions is a leading Blow-Fill-Seal (“BFS”) sterile contract development and manufacturing organization that focuses on complex clinical to commercial stage formulation and manufacturing. The Company supports a global, blue-chip customer base with a broad array of products that leverage its BFS sterile manufacturing capabilities and formulation competency in complex chemistries, including small molecule, biologics, macromolecules and potent compounds.

SK Capital acquired Woodstock Sterile Solutions from Catalent Pharma Solutions, LLC in March 2021.

For more information, please visit https://woodstocksterilesolutions.com/